View.rightful But Dead Serious Drug Side Effects Tell your doctor if you have recently had an MRI magnetic resonance imaging or any type of scan using a radioactive dye that is injected into your veins. exciter lasers also can correct astigmatism by smoothing an irregular cornea into a more normal shape. London Laser Eye Surgeon Advice – YouTubeFormer FDA chief, turned whistle-blower, exposes corruption surrounding FDA-approval of LASIK devices. Do not take more La six than your recommended dose. LasikTube – Videos and News Reports Watch stories of LASIK disasters. We apologize for any inconvenience. LASIK is an unnecessary surgical procedure that carries risk to the organ through which we get 80% of our information. Read Information Suppressed .
Corneal specialists at the Salt Lake City eye surgery and vision care center, a comprehensive specialty eye care practice, have been successfully using corneal cross-linking therapy to treat keratoconus patients through clinical trials for several years. The Avedro Corneal Cross-Linking (KXL) treatment is the first and only FDA-approved treatment available in the U.S. “We have a large community of keratoconus patients that has been anxiously awaiting FDA approval of corneal cross-linking,” explained Dr. Darcy Wolsey, cornea and refractive specialist at The Eye Institute of Utah. “We have experienced very positive results with cross-linking during clinical trials, and we are thrilled to extend this treatment option to patients in need.” Despite receiving FDA-approval for the Avedro Corneal Cross-Linking treatment in April 2016, practices across the U.S. had to wait to offer the approved KXL treatment until receiving shipments of the FDA-approved photo enhancers used for the treatment, Photrexa and Photrexa Viscous. Keratoconus is the most common corneal dystrophy in the U.S., affecting approximately 1 in every 2,000 people. Keratoconus is a progressive eye disease that occurs when the front of the eye, called the cornea, thins and bulges into a cone-like shape. This causes significant visual distortion, progressive myopia, and may even lead to the need for corneal transplant surgery. Corneal cross-linking is considered one of the most effective treatments for slowing or halting the progression of keratoconus and preventing the need for surgical intervention. Corneal cross-linking is a minimally invasive treatment that lasts approximately 60-90 minutes.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/salt-lake-city-eye-doctors-130100184.html
<iframe width="560" height="315" src="http://www.youtube.com/watch?https://youtube.com/watch?v=lM19cvuWMcsfeature=youtube_gdata&v=0oSq1pQv9Vo” frameborder=”0″ allowfullscreen>